| 生物活性 | hCAII-IN-9 is a potentcarbonic anhydrase inhibitor withIC50s of 1.18 μM (hCA II), 0.17 μM (hCA IX), and 2.99 μM (hCA XII), respectively. hCAII-IN-9 has no blood-brain barrier permeability[1]. | |||
| IC50& Target[1] |
| |||
| 体外研究 (In Vitro) | hCAII-IN-9 (compound 11) (100 μM; 24-48 h) inhibits BHK-21 and HEK-293 cells with cell viability rates of 48% and 72%[1]. | |||
| 体内研究 (In Vivo) | hCAII-IN-9 (compound 11) has no blood-brain barrier permeability[1]. | |||
| 分子量 | 417.89 | |||
| Formula | C15H16ClN3O5S2 | |||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | |||
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
| 维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2026 |
